In addition to H19, PVT1 has been shown to increase EMT in pancreatic cancer tissue by activating the TGF-β/SMAD signaling pathway and inducing proliferation and metastasis by inhibiting SERPINE1 mRNA binding protein 1 (SERBP1). This evidence concerns the gene H19 and familial pancreatic carcinoma.